Skip to main content
Premium Trial:

Request an Annual Quote

Berlex Expands License to Biotique s BLIS Platform

NEW YORK, Jan. 19 (GenomeWeb News) - Berlex Biosciences, the US affiliate of Schering, has expanded its license to Biotique Systems' BLIS platform, Biotique said today.


Berlex obtained a three-year license to the Biotique Local Integration System that provides worldwide access to Schering's research operations. Under a previous agreement, Berlex had licensed BLIS for its research site in Richmond, Calif.


Biotique, based in Emeryville, Calif., offers BLIS as a framework for biological data integration. Its customers include Merck, Bristol-Myers Squibb, Monsanto, and Affymetrix.


The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.